Abstract
ObjectiveSeveral glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1Ra) have been made recently available in Spain for type 2 diabetes mellitus (DM2) treatment. There are no published data on the clinical and...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have